LDLR and atherosclerosis: Using murine models of atherosclerosis (Apoe−/− and LDLr−/− mice) and human coronary artery lesions, in situ proliferation of lesion‐resident cells at different stages of growth was assessed by staining for Ki67 and bromodeoxyuridine (BrdU).